US approves to a $3.2 billion agreement for Pfizer’s Omicron
US pfizer’s Omicron approves $3.2 billion deal to purchase 105 million doses of the BioNTech/Pfizer vaccine. The deal includes a planned new vaccine targeting the Omicron strain for the fall booster campaign. An additional 195 million vaccines have not yet been approved by the FDA. Pfizer’s Omicron: The Biden Administration has approved a $3.2 billion deal to purchase 105 million
